{"title":"The role of uropathogenic <i>Escherichia coli</i> virulence factors in the development of urinary tract infection.","authors":"Ketema Bizuwork Gebremedhin, Wondwossen Amogne, Haile Alemayehu, Shubhada Bopegamage, Tadesse Eguale","doi":"10.25122/jml-2024-0396","DOIUrl":null,"url":null,"abstract":"<p><p>Urinary tract infections (UTIs) are a significant global public health issue, with <i>Escherichia coli (E. coli)</i>, specifically uropathogenic <i>E. coli</i> (UPEC), being the predominant causative agent. UTIs affect millions of people annually, with a particularly high prevalence among women, children, the elderly, and individuals with compromised immunity or structural abnormalities of the urinary tract. UPEC has evolved a suite of specialized virulence factors like adhesins, flagella, capsular polysaccharides, lipopolysaccharide (LPS), outer membrane vesicles (OMVs), toxins, iron acquisition systems, autotransporters (ATs), and unique proteins such as TcpC and OmpT, that facilitate colonization, immune evasion, and disease progression. These factors enable the pathogen to cause both uncomplicated infections, such as cystitis, and more severe outcomes, including pyelonephritis and, in some cases, renal failure. The host defends against infection through mechanisms such as urine flow, urothelial shedding, cytokine release, antimicrobial peptides, and adaptive immunity. Despite advancements in medical care, the burden of UTIs remains high, underscoring the need for continued research into their pathogenesis and prevention.</p>","PeriodicalId":16386,"journal":{"name":"Journal of Medicine and Life","volume":"18 8","pages":"701-709"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467495/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicine and Life","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25122/jml-2024-0396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Urinary tract infections (UTIs) are a significant global public health issue, with Escherichia coli (E. coli), specifically uropathogenic E. coli (UPEC), being the predominant causative agent. UTIs affect millions of people annually, with a particularly high prevalence among women, children, the elderly, and individuals with compromised immunity or structural abnormalities of the urinary tract. UPEC has evolved a suite of specialized virulence factors like adhesins, flagella, capsular polysaccharides, lipopolysaccharide (LPS), outer membrane vesicles (OMVs), toxins, iron acquisition systems, autotransporters (ATs), and unique proteins such as TcpC and OmpT, that facilitate colonization, immune evasion, and disease progression. These factors enable the pathogen to cause both uncomplicated infections, such as cystitis, and more severe outcomes, including pyelonephritis and, in some cases, renal failure. The host defends against infection through mechanisms such as urine flow, urothelial shedding, cytokine release, antimicrobial peptides, and adaptive immunity. Despite advancements in medical care, the burden of UTIs remains high, underscoring the need for continued research into their pathogenesis and prevention.
期刊介绍:
The Journal of Medicine and Life publishes peer-reviewed articles from various fields of medicine and life sciences, including original research, systematic reviews, special reports, case presentations, major medical breakthroughs and letters to the editor. The Journal focuses on current matters that lie at the intersection of biomedical science and clinical practice and strives to present this information to inform health care delivery and improve patient outcomes. Papers addressing topics such as neuroprotection, neurorehabilitation, neuroplasticity, and neuroregeneration are particularly encouraged, as part of the Journal''s continuous interest in neuroscience research. The Editorial Board of the Journal of Medicine and Life is open to consider manuscripts from all levels of research and areas of biological sciences, including fundamental, experimental or clinical research and matters of public health. As part of our pledge to promote an educational and community-building environment, our issues feature sections designated to informing our readers regarding exciting international congresses, teaching courses and relevant institutional-level events.